Jonathan A. Hensel

779 total citations
23 papers, 607 citations indexed

About

Jonathan A. Hensel is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jonathan A. Hensel has authored 23 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Jonathan A. Hensel's work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jonathan A. Hensel is often cited by papers focused on CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jonathan A. Hensel collaborates with scholars based in United States and Germany. Jonathan A. Hensel's co-authors include Selvarangan Ponnazhagan, Anandi Sawant, Diptiman Chanda, Gene P. Siegal, Akhil Maheshwari, Dan Theodorescu, Thomas W. Flaig, Sanjay Kumar, William E. Grizzle and Tatyana Isayeva and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jonathan A. Hensel

22 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan A. Hensel United States 14 307 234 230 102 80 23 607
Eugenie Kleinerman United States 15 249 0.8× 297 1.3× 369 1.6× 176 1.7× 112 1.4× 24 783
Jérôme Perrard United States 10 196 0.6× 271 1.2× 280 1.2× 59 0.6× 123 1.5× 15 711
Haizhou Xing China 11 208 0.7× 180 0.8× 192 0.8× 78 0.8× 81 1.0× 31 561
Sabine Muth Germany 10 315 1.0× 328 1.4× 134 0.6× 87 0.9× 32 0.4× 19 624
Qianqian Duan China 7 378 1.2× 340 1.5× 293 1.3× 169 1.7× 138 1.7× 31 792
Anna Merlo Italy 17 384 1.3× 254 1.1× 332 1.4× 50 0.5× 115 1.4× 32 825
Michael Shepard United States 7 380 1.2× 259 1.1× 238 1.0× 59 0.6× 46 0.6× 13 747
J Seifert Austria 5 183 0.6× 269 1.1× 308 1.3× 42 0.4× 49 0.6× 6 690
Christelle P El-Haibi United States 7 245 0.8× 152 0.6× 179 0.8× 50 0.5× 80 1.0× 11 487
Herbert R. Lamche Austria 9 249 0.8× 163 0.7× 194 0.8× 29 0.3× 92 1.1× 18 542

Countries citing papers authored by Jonathan A. Hensel

Since Specialization
Citations

This map shows the geographic impact of Jonathan A. Hensel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Hensel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Hensel more than expected).

Fields of papers citing papers by Jonathan A. Hensel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A. Hensel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Hensel. The network helps show where Jonathan A. Hensel may publish in the future.

Co-authorship network of co-authors of Jonathan A. Hensel

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan A. Hensel. A scholar is included among the top collaborators of Jonathan A. Hensel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan A. Hensel. Jonathan A. Hensel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hensel, Jonathan A., Odion Binitie, Caroline Chebli, et al.. (2024). Expansion of tumor-infiltrating and marrow-infiltrating lymphocytes from pediatric malignant solid tumors. Cytotherapy. 27(1). 29–35. 2 indexed citations
2.
Hensel, Jonathan A., Christopher Cubitt, Michael J. Schell, et al.. (2023). SARS-CoV-2 antibody response duration and neutralization following natural infection. SHILAP Revista de lepidopterología. 3(3). 100158–100158.
3.
Hensel, Jonathan A., Yun Lü, Anna G. Sorace, et al.. (2022). Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival. Molecular Cancer Therapeutics. 21(11). 1710–1721. 4 indexed citations
4.
Hensel, Jonathan A., et al.. (2022). Adoptive Cellular Therapy for Pediatric Solid Tumors: Beyond Chimeric Antigen Receptor-T Cell Therapy. The Cancer Journal. 28(4). 322–327. 2 indexed citations
5.
Giuliano, Anna R., Jeffrey E. Lancet, Shari Pilon‐Thomas, et al.. (2022). Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida. JAMA Oncology. 8(5). 748–748. 17 indexed citations
6.
Hensel, Jonathan A., et al.. (2021). 178 Expansion of Tumor-Infiltrating Lymphocytes and Marrow-Infiltrating Lymphocytes from Pediatric Malignant Solid Tumors. Regular and Young Investigator Award Abstracts. A190–A190. 1 indexed citations
7.
Hensel, Jonathan A., et al.. (2021). 179 CD8+CD69+ Expanded Tumor Infiltrating Lymphocytes from Soft Tissue Sarcoma Have Increased Tumor-Specific Functional Capacity. SHILAP Revista de lepidopterología. A191–A191. 2 indexed citations
8.
Mullinax, John E., MacLean Hall, Matthew Beatty, et al.. (2021). Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function. Journal of Immunotherapy. 44(2). 63–70. 34 indexed citations
9.
Wang, Hong, Jonathan A. Hensel, Joo Hyoung Lee, et al.. (2020). RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity. Molecular Cancer Therapeutics. 19(12). 2585–2597. 7 indexed citations
10.
Hensel, Jonathan A., et al.. (2018). Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity. Molecular Therapy — Oncolytics. 12. 41–48. 37 indexed citations
11.
Hensel, Jonathan A., et al.. (2018). Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations. Laboratory Investigation. 99(1). 93–106. 79 indexed citations
12.
Hensel, Jonathan A., et al.. (2017). Location of tumor affects local and distant immune cell type and number. Immunity Inflammation and Disease. 5(1). 85–94. 14 indexed citations
13.
Chanda, Diptiman, et al.. (2017). Effects of Cellular Methylation on Transgene Expression and Site-Specific Integration of Adeno-Associated Virus. Genes. 8(9). 232–232. 16 indexed citations
14.
Feduska, Joseph M., et al.. (2016). Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade. Bone. 93. 113–124. 18 indexed citations
15.
Hensel, Jonathan A., Jason E. Duex, Charles R. Owens, et al.. (2015). Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors. Molecular Cancer Research. 13(9). 1306–1315. 25 indexed citations
16.
Chanda, Diptiman, Joo Hyoung Lee, Anandi Sawant, et al.. (2014). Anterior Gradient Protein-2 Is a Regulator of Cellular Adhesion in Prostate Cancer. PLoS ONE. 9(2). e89940–e89940. 16 indexed citations
17.
Hensel, Jonathan A., Thomas W. Flaig, & Dan Theodorescu. (2012). Clinical opportunities and challenges in targeting tumour dormancy. Nature Reviews Clinical Oncology. 10(1). 41–51. 52 indexed citations
18.
Sawant, Anandi, Jonathan A. Hensel, Diptiman Chanda, et al.. (2012). Depletion of Plasmacytoid Dendritic Cells Inhibits Tumor Growth and Prevents Bone Metastasis of Breast Cancer Cells. The Journal of Immunology. 189(9). 4258–4265. 154 indexed citations
19.
Hensel, Jonathan A., Diptiman Chanda, Sanjay Kumar, et al.. (2010). LL‐37 as a therapeutic target for late stage prostate cancer. The Prostate. 71(6). 659–670. 43 indexed citations
20.
Chanda, Diptiman, Tatyana Isayeva, Sanjay Kumar, et al.. (2009). Therapeutic Potential of Adult Bone Marrow–Derived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis. Clinical Cancer Research. 15(23). 7175–7185. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenie Kleinerman Breakdown of academic impact, for papers by Jérôme Perrard Breakdown of academic impact, for papers by Haizhou Xing Breakdown of academic impact, for papers by Sabine Muth Breakdown of academic impact, for papers by Qianqian Duan Breakdown of academic impact, for papers by Anna Merlo Breakdown of academic impact, for papers by Michael Shepard Breakdown of academic impact, for papers by J Seifert Breakdown of academic impact, for papers by Christelle P El-Haibi Breakdown of academic impact, for papers by Herbert R. Lamche
Rankless by CCL
2026